Akeem Yusuf

1.7k total citations
34 papers, 362 citations indexed

About

Akeem Yusuf is a scholar working on Hematology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Akeem Yusuf has authored 34 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 11 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Akeem Yusuf's work include Multiple Myeloma Research and Treatments (12 papers), Protein Degradation and Inhibitors (7 papers) and Parathyroid Disorders and Treatments (4 papers). Akeem Yusuf is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Protein Degradation and Inhibitors (7 papers) and Parathyroid Disorders and Treatments (4 papers). Akeem Yusuf collaborates with scholars based in United States, United Kingdom and Germany. Akeem Yusuf's co-authors include Yan Hu, Bhupinder Singh, James B. Wetmore, Wendy L. St. Peter, Richard Barron, David Chandler, Andreas Grauer, Yi Peng, Haifeng Guo and Jincheng Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and American Journal of Kidney Diseases.

In The Last Decade

Akeem Yusuf

30 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akeem Yusuf United States 10 99 97 87 68 58 34 362
Agnès Räkel Canada 13 30 0.3× 32 0.3× 91 1.0× 155 2.3× 61 1.1× 24 413
Verónica Escudero Spain 10 41 0.4× 92 0.9× 43 0.5× 208 3.1× 33 0.6× 21 370
Joanne W. Elena United States 8 22 0.2× 62 0.6× 78 0.9× 34 0.5× 41 0.7× 11 630
Nissenson Ar United States 9 67 0.7× 61 0.6× 61 0.7× 217 3.2× 26 0.4× 17 486
S. Stefoni Italy 11 20 0.2× 95 1.0× 119 1.4× 160 2.4× 52 0.9× 32 392
Rosilene M. Elias Brazil 13 51 0.5× 46 0.5× 39 0.4× 229 3.4× 15 0.3× 26 437
Anuja Mittalhenkle United States 12 162 1.6× 55 0.6× 157 1.8× 306 4.5× 29 0.5× 15 561
Zhimin Chen China 11 59 0.6× 49 0.5× 89 1.0× 211 3.1× 25 0.4× 32 349
L. Tougaard Denmark 13 81 0.8× 90 0.9× 112 1.3× 114 1.7× 13 0.2× 35 433
Ekrem Kara Türkiye 12 14 0.1× 45 0.5× 62 0.7× 176 2.6× 37 0.6× 43 409

Countries citing papers authored by Akeem Yusuf

Since Specialization
Citations

This map shows the geographic impact of Akeem Yusuf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akeem Yusuf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akeem Yusuf more than expected).

Fields of papers citing papers by Akeem Yusuf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akeem Yusuf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akeem Yusuf. The network helps show where Akeem Yusuf may publish in the future.

Co-authorship network of co-authors of Akeem Yusuf

This figure shows the co-authorship network connecting the top 25 collaborators of Akeem Yusuf. A scholar is included among the top collaborators of Akeem Yusuf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akeem Yusuf. Akeem Yusuf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wainberg, Zev A., Shukui Qin, Jinyi Wang, et al.. (2024). Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer. SHILAP Revista de lepidopterología. 6. 100095–100095.
3.
Moreau, Philippe, Sosana Delimpasi, Eirini Katodritou, et al.. (2021). P-206: SELECT Trial in Progress: an open-label, phase 2 study of Carfilzomib, Pomalidomide, and Dexamethasone in patients with first or second relapse of Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 21. S152–S152. 1 indexed citations
4.
Yusuf, Akeem, et al.. (2020). Predictors of imminent risk of fracture in Medicare-enrolled men and women. Archives of Osteoporosis. 15(1). 120–120. 17 indexed citations
5.
6.
Li, Shuling, Jiannong Liu, Vicki A. Morrison, et al.. (2019). Mortality by a proxy performance status as defined by a claims-based measure for disability status in older patients with newly diagnosed multiple myeloma in the United States. Journal of Geriatric Oncology. 10(3). 490–496. 3 indexed citations
7.
8.
Yusuf, Akeem, Steven R. Cummings, Nelson B. Watts, et al.. (2018). Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women. Archives of Osteoporosis. 13(1). 33–33. 51 indexed citations
9.
Yusuf, Akeem, et al.. (2016). Serum Potassium Levels and Mortality in Hemodialysis Patients: A Retrospective Cohort Study. American Journal of Nephrology. 44(3). 179–186. 72 indexed citations
10.
Block, Geoffrey A., Akeem Yusuf, Mark D. Danese, et al.. (2016). Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis. BMC Nephrology. 17(1). 166–166. 4 indexed citations
11.
Yusuf, Akeem, et al.. (2016). Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries. Archives of Osteoporosis. 11(1). 31–31. 42 indexed citations
12.
Li, Shuling, et al.. (2016). Treatment Sequencing Patterns in Medicare-Enrolled Patients with Multiple Myeloma. Blood. 128(22). 2120–2120. 1 indexed citations
13.
Peter, Wendy L. St., Akeem Yusuf, Kimberly A. Lowe, et al.. (2015). Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: a retrospective cohort study. BMC Nephrology. 16(1). 41–41. 3 indexed citations
14.
Park, Taehwan, Akeem Yusuf, & Ronald S. Hadsall. (2015). Pharmacy Students’ Attitudes Toward Debt. American Journal of Pharmaceutical Education. 79(4). 52–52. 9 indexed citations
15.
Yusuf, Akeem, et al.. (2015). Hospitalization Rates for Newly Diagnosed Multiple Myeloma Patients in the United States Medicare Database. Clinical Lymphoma Myeloma & Leukemia. 15. e185–e185.
16.
Yusuf, Akeem, Eric D. Weinhandl, & Wendy L. St. Peter. (2014). Comparative Effectiveness of Calcium Acetate and Sevelamer on Clinical Outcomes in Elderly Hemodialysis Patients Enrolled in Medicare Part D. American Journal of Kidney Diseases. 64(1). 95–103. 15 indexed citations
17.
Yusuf, Akeem, Benjamin L. Howell, Christopher A. Powers, & Wendy L. St. Peter. (2014). Utilization and Costs of Medications Associated With CKD Mineral and Bone Disorder in Dialysis Patients Enrolled in Medicare Part D. American Journal of Kidney Diseases. 64(5). 770–780. 24 indexed citations
18.
Schommer, Jon C., Akeem Yusuf, & Ronald S. Hadsall. (2013). Market dynamics of community pharmacies in Minnesota, U.S. from 1992 through 2012. Research in Social and Administrative Pharmacy. 10(1). 217–231. 9 indexed citations
19.
Yusuf, Akeem & Wendy L. St. Peter. (2012). PUK6 Medication Adherence in Hemodialysis Patients Treated with Phosphate Binders. Value in Health. 15(4). A153–A153. 1 indexed citations
20.
Yusuff, Kazeem B. & Akeem Yusuf. (2009). Advertising of OTC products in a Nigerian urban setting: Content analysis for indications, targets, and advertising appeal. Journal of the American Pharmacists Association. 49(3). 432–435. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agnès Räkel Breakdown of academic impact, for papers by Verónica Escudero Breakdown of academic impact, for papers by Joanne W. Elena Breakdown of academic impact, for papers by Nissenson Ar Breakdown of academic impact, for papers by S. Stefoni Breakdown of academic impact, for papers by Rosilene M. Elias Breakdown of academic impact, for papers by Anuja Mittalhenkle Breakdown of academic impact, for papers by Zhimin Chen Breakdown of academic impact, for papers by L. Tougaard Breakdown of academic impact, for papers by Ekrem Kara
Rankless by CCL
2026